CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug–Drug Interaction Modeling

Clicks: 17
ID: 337638
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #696 of 983 articles by views in BMC Bioinformatics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 983 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
MOTIVATION: Drug-drug interaction (DDI) prediction is critical for drug safety, yet existing methods suffer from structural incompleteness in drug representation. Motif and molecular graph encodings capture local substructures and global topology but remain confined to the closed structural space of individual molecules, lacking cross-entity and contextual information and leading to limited generalization, especially in cold-start scenarios. To address this issue, we propose CSK-DDI, a multimodal framework that jointly encodes motif-level chemical patterns, molecular graph topology, and biomedical knowledge graph context as complementary drug representations. The KG encodes drugs' contextual positions and relational semantics through multi-entity and multi-relation connections, providing global cross-entity and cross-semantic information that complements structural representations. The resulting fusion captures local chemical patterns, global topology, and biomedical context in a unified embedding. RESULTS: CSK-DDI employs a cross-attention mechanism to enable multi-view interaction among motif, molecular graph, and knowledge graph representations, producing unified structure-aware and context-aware drug embeddings. To improve robustness under sparse conditions, the model further incorporates a cold-start-oriented representation enhancement strategy. Experiments on benchmark datasets demonstrate consistent improvements over state-of-the-art methods, with particularly notable gains in cold-start scenarios. AVAILABILITY: Source code and data are available at https://github.com/cgwcbz2/CSK-DDI and on Zenodo at https://doi.org/10.5281/zenodo.21415769. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Reference Key
openalex_W7224129602 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal BMC Bioinformatics
Year 2026
DOI
10.1093/bioinformatics/btag800
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.